Intervention Review

Botulinum toxin type A therapy for hemifacial spasm

  1. João Costa1,*,
  2. Cláudia C Espírito-Santo1,
  3. Ana A Borges1,
  4. Joaquim Ferreira1,
  5. Miguel M Coelho1,
  6. Peter Moore2,
  7. Cristina Sampaio1

Editorial Group: Cochrane Movement Disorders Group

Published Online: 24 JAN 2005

Assessed as up-to-date: 24 OCT 2004

DOI: 10.1002/14651858.CD004899.pub2


How to Cite

Costa J, Espírito-Santo CC, Borges AA, Ferreira J, Coelho MM, Moore P, Sampaio C. Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004899. DOI: 10.1002/14651858.CD004899.pub2.

Author Information

  1. 1

    Faculdade de Medicina de Lisboa, Laboratório de Farmacologia Clínica e Terapêutica, Lisboa, Portugal

  2. 2

    NHS Trust, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK

*João Costa, Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Lisboa, 1649-028, Portugal. joaoncosta@sapo.pt.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2005

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sheng Chen, Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments, Toxins, 2012, 4, 12, 913

    CrossRef

  2. 2
    M. Vidailhet, La toxine botulique en Neurologie, La Revue de Médecine Interne, 2005, 26, 7, 531

    CrossRef